The effect of tranexamic acid and hydroquinone in melasma
Phase 3
Recruiting
- Conditions
- Melasma.
- Registration Number
- IRCT20180909040979N5
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 48
Inclusion Criteria
Female sex
Being at the age of 18-50 years old
Facial melasma
Exclusion Criteria
Pregnant and lactating women
History of melasma treatment over the past month
Active herpes simplex lesions on the face
Sensitivity to the drugs in the study
Coagulopathy
Warts on the face
Use of anticoagulant and anticonvulsant drugs
Contraceptive use during the past 12 months and during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The degree of melasma treatment. Timepoint: Before treatment, at 4th, 8th and 12th week during the treatment and three months after the end of the treatment. Method of measurement: MASI score.
- Secondary Outcome Measures
Name Time Method